Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer Meeting Abstract


Authors: Touijer, K. A.; Carver, B. S.; Coleman, J. A.; Laudone, V. P.; Hullings, M.; Ehrlich, S. S.; DeNunzio, M.; Reuter, V. E.; Eastham, J. A.; Danila, D. C.; Slovin, S. F.; Morris, M. J.; Chen, Y.; Scardino, P. T.; Scher, H. I.; Rathkopf, D. E.
Abstract Title: Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202142
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.TPS5105
Notes: Meeting Abstract: TPS5105 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    349 Coleman
  2. Vincent Laudone
    140 Laudone
  3. Susan Slovin
    254 Slovin
  4. Michael Morris
    586 Morris
  5. Peter T Scardino
    671 Scardino
  6. Yu Chen
    134 Chen
  7. Karim Abdelkrim Touijer
    260 Touijer
  8. Dana Elizabeth Rathkopf
    275 Rathkopf
  9. James Eastham
    541 Eastham
  10. Brett Stewart Carver
    143 Carver
  11. Victor Reuter
    1232 Reuter
  12. Howard Scher
    1131 Scher
  13. Daniel C Danila
    155 Danila